Author:
Fan Lei,Yang Hong,Hu Xiangnan,Liu Juncheng,You Yuehua,Li Xinyu,Qin Guangcheng,Ge Qian,Hou Yi,Xiao Xiaoqiu
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference45 articles.
1. Current anti-diabetic agents and their molecular targets: a review;Kerru;Eur. J. Med. Chem.,2018
2. CMD-05, a novel promising clinical anti-diabetic drug candidate, in vivo and vitro studies;Ma;Sci. Rep.,2017
3. First-in-human, double-blind, randomized, placebo-controlled trial of TQ-F3083, a new dipeptidyl Peptidase-4 inhibitor, in healthy Chinese adults;Liu;Front. Pharmacol.,2021
4. GLP-1 analogs and DPP-4 inhibitors in type 2 diabetes therapy: review of head-to-head clinical trials;Gilbert;Front. Endocrinol. (Lausanne),2020
5. Central and peripheral GLP-1 systems independently suppress eating;Brierley;Nat. Metab.,2021